Patents by Inventor Christopher A. Traina

Christopher A. Traina has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230040919
    Abstract: The present disclosure relates to a crosslinked macromolecular matrix comprising lysine; hyaluronic acid; and collagen; wherein the hyaluronic acid is crosslinked to the collagen by at least one endogenous amine group on the collagen and/or by at least one amine group present on the lysine.
    Type: Application
    Filed: December 28, 2019
    Publication date: February 9, 2023
    Inventors: Christopher A. TRAINA, Artem B. KUTIKOV, Xiaojie YU, Christopher K. HEE, Darin J. MESSINA, Julie MORELL, Florent DURIEUX, Olivier GUETTA, Jean-Xavier ROCA MARTINEZ
  • Patent number: 9072789
    Abstract: Oxide, oxysulfide, or phosphate host particles with a self-assembled organo-phosphonate monolayer covalently bonded thereto are disclosed. Methods for coating the host particles and use of rare earth ion-doped particles in imaging methods and photodynamic therapy methods are also disclosed.
    Type: Grant
    Filed: July 19, 2008
    Date of Patent: July 7, 2015
    Assignee: The Trustees of Princeton University
    Inventors: Jeffrey Schwartz, Christopher A. Traina
  • Patent number: 8372435
    Abstract: Nanoparticles are functionalized for use as bio-imaging probes using a novel, modular approach. Particle surface modification is based on a phosphonate monolayer platform on which was built a multi-segmented, multi-functional film: the first segment provided hydrolytic stability, the second aqueous suspendability, and the third, selectivity for cell attachment. In vitro imaging experiments visualized nanoparticle-cell surface binding. Peptide-derivatized nano-particles were not displaced from cells by soluble peptide. Methods for coating the host particles and use of rare earth ion-doped particles in imaging methods and photodynamic therapy methods are also disclosed.
    Type: Grant
    Filed: June 22, 2009
    Date of Patent: February 12, 2013
    Assignee: Princeton University
    Inventors: Jeffrey Schwartz, Christopher A. Traina, Thomas Joseph Dennes
  • Publication number: 20100034742
    Abstract: Nanoparticles are functionalized for use as bio-imaging probes using a novel, modular approach. Particle surface modification is based on a phosphonate monolayer platform on which was built a multi-segmented, multi-functional film: the first segment provided hydrolytic stability, the second aqueous suspendability, and the third, selectivity for cell attachment. In vitro imaging experiments visualized nanoparticle—cell surface binding. Peptide-derivatized nano-particles were not displaced from cells by soluble peptide. Methods for coating the host particles and use of rare earth ion-doped particles in imaging methods and photodynamic therapy methods are also disclosed.
    Type: Application
    Filed: June 22, 2009
    Publication date: February 11, 2010
    Applicant: PRINCETON UNIVERSITY
    Inventors: Jeffrey Schwartz, Christopher A. Traina, Thomas J. Dennes
  • Publication number: 20090028792
    Abstract: Oxide, oxysulfide, halide or phosphate host particles with a self-assembled organophosphonate monolayer covalently bonded thereto. Methods for coating the host particles and use of rare earth ion-doped particles in imaging methods and photodynamic therapy methods are also disclosed.
    Type: Application
    Filed: July 19, 2008
    Publication date: January 29, 2009
    Applicant: The Trustees of Princeton University
    Inventors: Jeffrey Schwartz, Christopher A. Traina